Recent Patents on Anti-Infective Drug Discovery
Title:Nanomedicine Advances in Topical Infective and Non-Infective Skin Diseases Therapy
Volume: 13 Issue: 2
Author(s): Mahfoozur Rahman, Sohail Akhter and Sarwar Beg
Affiliation:
Export Options
About this article
Cite this article as:
Rahman Mahfoozur , Akhter Sohail and Beg Sarwar , Nanomedicine Advances in Topical Infective and Non-Infective Skin Diseases Therapy, Recent Patents on Anti-Infective Drug Discovery 2018; 13 (2) . https://dx.doi.org/10.2174/1574891X1302181106123659
DOI https://dx.doi.org/10.2174/1574891X1302181106123659 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
30
6
Related Articles
-
Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
Current Stem Cell Research & Therapy DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Functionalized Upconversion Nanoparticles: Versatile Nanoplatforms for Translational Research
Current Molecular Medicine Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Recent Advances in Validating MDM2 as a Cancer Target
Anti-Cancer Agents in Medicinal Chemistry Infringement of the Barriers of Cancer Via Dietary Phytoconstituents Capsaicin Through Novel Drug Delivery System
Current Drug Delivery Antibiotics with Antiviral and Anti-Inflammatory Potential Against Covid-19: A Review
Current Reviews in Clinical and Experimental Pharmacology Liposome-Nanogel Structures for Future Pharmaceutical Applications: An Updated Review
Current Pharmaceutical Design Editorial (Hot Topic: Coming Back to Nature: Plants as a Vital Source of Pharmaceutically Important Metabolites – Part II A)
Current Medicinal Chemistry Anti-VEGF Anticancer Drugs: Mind the Hypertension
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Asymmetric Syntheses Based on Organocatalysis
Mini-Reviews in Organic Chemistry Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy
Current Molecular Medicine Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial
Reviews on Recent Clinical Trials Resveratrol and Cancer Treatment: Is Hormesis a Yet Unsolved Matter?
Current Pharmaceutical Design Pleural Involvement Due to Metastatic Melanoma: A Rare Complication and Literature Review
Current Respiratory Medicine Reviews Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Current Genomics Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design